World / Cancer

First Day Of Ovarian Cancer Symposium Focuses On Early Detection - Ovarian Cancer Research Symposium

First Day Of Ovarian Cancer Symposium Focuses On Early Detection - Ovarian Cancer Research Symposium

Time 06.09.2008 10:12 Source  medicalnewstoday.com

Leading ovarian cancer researchers and clinicians from around the world gathered at the Ovarian Cancer Research Symposium today to hear about cutting-edge developments that may increase the chances of early detection of the disease. Dr. Patricia Kruk, from the University of South Florida, presented her research that could lead to using a non-invasive urine test for detecting ovarian cancer.

Region World Category Cancer
Elan And Biogen Idec Initiate First Clinical Trial Of TYSABRI(R) In Oncology - First Multiple Myeloma Patient Treated

Elan And Biogen Idec Initiate First Clinical Trial Of TYSABRI(R) In Oncology - First Multiple Myeloma Patient Treated

Time 06.09.2008 08:12 Source  medicalnewstoday.com

Elan Corporation, plc (NYSE: ELN) and Biogen Idec (NASDAQ: BIIB) announced the initiation of the first clinical trial of TYSABRI® (natalizumab) in oncology. The first dose of TYSABRI was administered yesterday in the trial. The objectives of this Phase I/II study are to evaluate the safety and potential anti-tumor activity of TYSABRI in patients with relapsed or refractory multiple myeloma.

Region World Category Cancer
Amrubicin Receives FDA Fast Track Designation For The Treatment Of Small Cell Lung Cancer After First-Line Chemotherapy

Amrubicin Receives FDA Fast Track Designation For The Treatment Of Small Cell Lung Cancer After First-Line Chemotherapy

Time 06.09.2008 06:13 Source  medicalnewstoday.com

Celgene Corporation (NASDAQ: CELG) announced that Amrubicin has been granted Fast Track product designation by the U.S. Food and Drug Administration (FDA) for the treatment of small cell lung cancer after first-line chemotherapy.

Region World Category Cancer
After A Liver Operation, African-Americans At Twice The Risk Of Death As Caucasians

After A Liver Operation, African-Americans At Twice The Risk Of Death As Caucasians

Time 06.09.2008 04:11 Source  medicalnewstoday.com

New research published in the Journal of the American College of Surgeons shows African Americans are more than twice as likely as Caucasians to die in the hospital after surgical removal of part of the liver -- an increasingly used procedure for the treatment of liver cancer. In recent years, a large body of evidence has emerged revealing significant racial disparities in health care and outcomes in the United States.

Region World Category Cancer
« Previous 0 Next »
« September 2008
SunMonTueWedThuFriSat
 010203040506
07080910111213
14151617181920
21222324252627
282930 

Date: 06 September 2008 - 11:20

Number of sources in English: 130